Main Article Content

Atta Muhammad Khan
Ziaullah Khan
Anila Basit
Mazhar Ali Khan
Amjad Ali


Type 2 Diabetes Mellitus, Inadequate Treatment, Consequences, Causes, Care


Objective: This study aims to shed light on the causes and consequences of insufficient treatment for type 2 diabetes.

Study Design: A cross-sectional study.

Place and Duration of the Study: Department of Medicine, MTI, LRH Peshawar, Pakistan, from 05 july 2022, to sep 05, 2022.

Methods: There were ninety-nine individuals with type 2 diabetes. The age range of the cases ranged from 18 to 75 years. Before collecting their demographic information, all participants were asked to give informed written consent. Additional information includes factors such as pre-existing conditions, weight, age, and smoking habits. Lifestyle management, vaccination, pharmaceutical therapy, laboratory assessment, and physical examination are the five areas that determine subpar care. We utilized SPSS 25.0 for the analysis of all data.

Results: Out of the total cases, 45 (50.2%) were males and 45 (44.8%) were females. The average age of the patients was 44.11±04.56 years, with an average BMI of 22.10±05.72 kg/m02. A significant number of cases, 38 (42.4%), were associated with individuals of low socio-economic status. Out of the total cases, 23 (26.4%) were smokers and 38 (43.4%) had HTN. The frequency of insufficient lifestyle management was 22 (22.4%), while inadequate immunization was reported in 30 cases (36.2%). In terms of pharmacological therapy, 40 cases (42.6%) were found to be inadequate. Additionally, 36 cases (39.2%) had insufficient physical examinations, and inadequate laboratory tests were identified in 24 cases (25.4%). 67% of cases revealed a significant lack of proper care.

Conclusion: Treatment of type 2 diabetes is riddled with widespread issues stemming from insufficient care. It was revealed that a significant majority of individuals encountered some level of inadequate care among the available options. Various factors, including systematic, medical professional, and individual variables, were found to contribute to below-average care delivery.

Abstract 38 | pdf Downloads 12


1. KUMAR A, BINDAL N, AGARWAL AK, HC M. An Open-label Prospective Study to Evaluate the Efficacy, Safety and Tolerability of Kenacort® Injection (Triamcinolone Acetonide) in the Treatment of Patients with Osteoarthritis, Rheumatoid Arthritis, Frozen Shoulder and Tennis Elbow. IJCP Group of Publications. 2017 Apr;27(11):1045.
2. Gyawali B, Ferrario A, van Teijlingen E, Kallestrup P. Challenges in diabetes mellitus type 2 management in Nepal: a literature review. Global health action. 2016 Dec 1;9(1):31704.
3. Campbell JA, Egede LE. Individual-, community-, and health system–level barriers to optimal type 2 diabetes care for inner-city African Americans: an integrative review and model development. The Diabetes Educator. 2020 Feb;46(1):11-27.
4. Arokiasamy P, Salvi S, Selvamani Y. Global burden of diabetes mellitus: prevalence, pattern, and trends. Handbook of Global Health. 2021:495-538.
5. Mattei J, Malik V, Wedick NM, Hu FB, Spiegelman D, Willett WC, Campos H, Global Nutrition Epidemiologic Transition Initiative. Reducing the global burden of type 2 diabetes by improving the quality of staple foods: The Global Nutrition and Epidemiologic Transition Initiative. Globalization and health. 2015 Dec;11:1-20.
6. Frühbeck G. Bariatric and metabolic surgery: a shift in eligibility and success criteria. Nature Reviews Endocrinology. 2015 Aug;11(8):465-77.
7. Kropp M, De Clerck E, Vo TT, Thumann G, Costigliola V, Golubnitschaja O. Unique metabolic signature of proliferative retinopathy in the tear fluid of diabetic patients with comorbidities—preliminary data for PM validation. EPMA Journal. 2023 Mar;14(1):43-51.
8. Songer TJ, Haymond MW, Glazner JE, Klingensmith GJ, Laffel LM, Zhang P, Hirst K, TODAY Study Group. Healthcare and associated costs related to type 2 diabetes in youth and adolescence: the TODAY clinical trial experience. Pediatric diabetes. 2019 Sep;20(6):702-11.
9. Chan JC, Zhang Y, Ning G. Diabetes in China: a societal solution for a personal challenge. The lancet Diabetes & endocrinology. 2014 Dec 1;2(12):969-79.
10. Patnaik PK, Jain KK, Chandra P, Pathak J, Raman KV, Shah A. Diabetes in India: Measuring the dynamics of a public health catastrophe. Journal of Social Health and Diabetes. 2016 Dec;4(02):077-84.
11. Zaharieva DP, Addala A, Simmons KM, Maahs DM. Weight management in youth with type 1 diabetes and obesity: challenges and possible solutions. Current obesity reports. 2020 Dec;9:412-23.
12. Ali MK, Narayan KV, Mohan V. Innovative research for equitable diabetes care in India. diabetes research and clinical practice. 2009 Dec 1;86(3):155-67.
13. Catapan SD, Nair U, Gray L, Cristina Marino Calvo M, Bird D, Janda M, Fatehi F, Menon A, Russell A. Same goals, different challenges: a systematic review of perspectives of people with diabetes and healthcare professionals on type 2 diabetes care. Diabetic Medicine. 2021 Sep;38(9):e14625.
14. Crowshoe L, Dannenbaum D, Green M, Henderson R, Hayward MN, Toth E, Diabetes Canada Clinical Practice Guidelines Expert Committee. Type 2 diabetes and Indigenous peoples. Canadian Journal of Diabetes. 2018 Apr 1;42:S296-306.
15. Zakir M, Ahuja N, Surksha MA, Sachdev R, Kalariya Y, Nasir M, Kashif M, Shahzeen F, Tayyab A, moazzam Khan MS, Junejo M. Cardiovascular complications of diabetes: from microvascular to macrovascular pathways. Cureus. 2023 Sep 24;15(9).
16. Olmos B. Healthcare Discrimination Trends and Associations With Chronic Illnesses, Depression, and Biomarkers Among Hispanic Older Adults Using Data From the Health and Retirement Study, 2010-2020 (Doctoral dissertation, The University of Oklahoma Health Sciences Center).
17. Teixeira da Silva D, Fialho A, Novas J. Environmental sustainability of hospital buildings–Literature review. EHMA 2022 Annual Conference.
18. Lewing B, Abughosh SM, Lal LS, Essien EJ, Sansgiry S, Sansgiry SS. Patient, physician, and health system factors associated with five types of inadequate care during management of type-2 diabetes mellitus in the United States. Diabetes Epidemiology and Management. 2022 Apr 1;6:100046.
19. Ruidar SB, Rizwan Z, Bashir A, Khan N, Khan MS, Mansoor Y. Inadequate Care During the Management of Type-2 Diabetes Mellitus: Prevalence and Associated Characteristics. Pakistan Journal of Medical & Health Sciences. 2022;16(12):566-.
20. Nigussie KA, Shegena EA, Stephen OP, Namugambe JS, Yadesa TM. Prevalence and factors associated with inappropriate anti-diabetic medication therapy among type 2 diabetes mellitus patients at the medical and surgical wards of Mbarara Regional Referral Hospital, Uganda. Plos one. 2022 Jun 29;17(6):e0270108.
21. Thabit MF. Awareness Regarding Diabetes Mellitus and Its Complications in Type 2 Diabetic Patients. AL-Kindy College Medical Journal. 2013 Jun 30;9(2):25-8.
22. Liu Z, Fu C, Wang W, Xu B. Prevalence of chronic complications of type 2 diabetes mellitus in outpatients-a cross-sectional hospital-based survey in urban China. Health and quality of life outcomes. 2010 Dec;8(1):1-9.
23. Danquah I, Bedu-Addo G, Terpe KJ, Micah F, Amoako YA, Awuku YA, Dietz E, van der Giet M, Spranger J, Mockenhaupt FP. Diabetes mellitus type 2 in urban Ghana: characteristics and associated factors. BMC Public Health. 2012 Dec;12:1-8.
24. Lewing B, Sansgiry S, Abughosh SM, Lal LS, Essien EJ, Sansgiry SS. Effect of inadequate care on diabetes complications and healthcare resource utilization during management of type 2 diabetes in the United States. Postgraduate Medicine. 2022 Jul 4;134(5):494-506.
25. Leite NC, Salles GF, Araujo AL, Villela‐Nogueira CA, Cardoso CR. Prevalence and associated factors of non‐alcoholic fatty liver disease in patients with type‐2 diabetes mellitus. Liver international. 2009 Jan;29(1):113-9.
26. Wens J, Vermeire E, Van Royen P, Sabbe B, Denekens J. GPs' perspectives of type 2 diabetes patients' adherence to treatment: A qualitative analysis of barriers and solutions. BMC family practice. 2005 Dec;6(1):1-0.

Most read articles by the same author(s)